Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 3
2013 6
2014 9
2015 4
2016 11
2017 11
2018 8
2019 3
2020 16
2021 38
2022 22
Text availability
Article attribute
Article type
Publication date

Search Results

119 results
Results by year
Filters applied: . Clear all
Page 1
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G, Myers R, Campbell CNJ, Amirthalingam G, Edmunds M, Zambon M, Brown KE, Hopkins S, Chand M, Ramsay M. Lopez Bernal J, et al. Among authors: amirthalingam g. N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21. N Engl J Med. 2021. PMID: 34289274 Free PMC article.
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.
Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, Gower C, Kall M, Groves N, O'Connell AM, Simons D, Blomquist PB, Zaidi A, Nash S, Iwani Binti Abdul Aziz N, Thelwall S, Dabrera G, Myers R, Amirthalingam G, Gharbia S, Barrett JC, Elson R, Ladhani SN, Ferguson N, Zambon M, Campbell CNJ, Brown K, Hopkins S, Chand M, Ramsay M, Lopez Bernal J. Andrews N, et al. Among authors: amirthalingam g. N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2. N Engl J Med. 2022. PMID: 35249272 Free PMC article.
Antibody response to SARS-CoV-2 infection in humans: A systematic review.
Post N, Eddy D, Huntley C, van Schalkwyk MCI, Shrotri M, Leeman D, Rigby S, Williams SV, Bermingham WH, Kellam P, Maher J, Shields AM, Amirthalingam G, Peacock SJ, Ismail SA. Post N, et al. Among authors: amirthalingam g. PLoS One. 2020 Dec 31;15(12):e0244126. doi: 10.1371/journal.pone.0244126. eCollection 2020. PLoS One. 2020. PMID: 33382764 Free PMC article.
T cell response to SARS-CoV-2 infection in humans: A systematic review.
Shrotri M, van Schalkwyk MCI, Post N, Eddy D, Huntley C, Leeman D, Rigby S, Williams SV, Bermingham WH, Kellam P, Maher J, Shields AM, Amirthalingam G, Peacock SJ, Ismail SA. Shrotri M, et al. Among authors: amirthalingam g. PLoS One. 2021 Jan 25;16(1):e0245532. doi: 10.1371/journal.pone.0245532. eCollection 2021. PLoS One. 2021. PMID: 33493185 Free PMC article.
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, Aiano F, Amin-Chowdhury Z, Hoschler K, Brooks T, Taylor S, Hewson J, Hallis B, Stapley L, Borrow R, Linley E, Ahmad S, Parker B, Horsley A, Amirthalingam G, Brown K, Ramsay ME, Ladhani S, Moss P. Zuo J, et al. Among authors: amirthalingam g. Nat Immunol. 2021 May;22(5):620-626. doi: 10.1038/s41590-021-00902-8. Epub 2021 Mar 5. Nat Immunol. 2021. PMID: 33674800 Free PMC article.
Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England.
Powell AA, Power L, Westrop S, McOwat K, Campbell H, Simmons R, Ramsay ME, Brown K, Ladhani SN, Amirthalingam G. Powell AA, et al. Among authors: amirthalingam g. Euro Surveill. 2021 Jul;26(28):2100634. doi: 10.2807/1560-7917.ES.2021.26.28.2100634. Euro Surveill. 2021. PMID: 34269172 Free PMC article.
Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines.
Andrews N, Tessier E, Stowe J, Gower C, Kirsebom F, Simmons R, Gallagher E, Thelwall S, Groves N, Dabrera G, Myers R, Campbell CNJ, Amirthalingam G, Edmunds M, Zambon M, Brown K, Hopkins S, Chand M, Ladhani SN, Ramsay M, Lopez Bernal J. Andrews N, et al. Among authors: amirthalingam g. N Engl J Med. 2022 Jan 27;386(4):340-350. doi: 10.1056/NEJMoa2115481. Epub 2022 Jan 12. N Engl J Med. 2022. PMID: 35021002 Free PMC article.
Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
Dowell AC, Butler MS, Jinks E, Tut G, Lancaster T, Sylla P, Begum J, Bruton R, Pearce H, Verma K, Logan N, Tyson G, Spalkova E, Margielewska-Davies S, Taylor GS, Syrimi E, Baawuah F, Beckmann J, Okike IO, Ahmad S, Garstang J, Brent AJ, Brent B, Ireland G, Aiano F, Amin-Chowdhury Z, Jones S, Borrow R, Linley E, Wright J, Azad R, Waiblinger D, Davis C, Thomson EC, Palmarini M, Willett BJ, Barclay WS, Poh J, Amirthalingam G, Brown KE, Ramsay ME, Zuo J, Moss P, Ladhani S. Dowell AC, et al. Among authors: amirthalingam g. Nat Immunol. 2022 Jan;23(1):40-49. doi: 10.1038/s41590-021-01089-8. Epub 2021 Dec 22. Nat Immunol. 2022. PMID: 34937928 Free PMC article.
Prioritising paediatric surveillance during the COVID-19 pandemic.
Ladhani SN, Amin-Chowdhury Z, Amirthalingam G, Demirjian A, Ramsay ME. Ladhani SN, et al. Among authors: amirthalingam g. Arch Dis Child. 2020 Jul;105(7):613-615. doi: 10.1136/archdischild-2020-319363. Epub 2020 May 7. Arch Dis Child. 2020. PMID: 32381519 No abstract available.
The Use of Quasi-experimental Designs for Vaccine Evaluation.
Lopez Bernal JA, Andrews N, Amirthalingam G. Lopez Bernal JA, et al. Among authors: amirthalingam g. Clin Infect Dis. 2019 May 2;68(10):1769-1776. doi: 10.1093/cid/ciy906. Clin Infect Dis. 2019. PMID: 30346524 Review.
119 results